New Clones on the Block
- PMID: 31618653
- DOI: 10.1016/j.immuni.2019.09.018
New Clones on the Block
Abstract
Although immune checkpoint blockade (ICB) has yielded striking clinical responses in subsets of cancer patients, the mechanism of action is still unclear. In a recent issue of Nature Medicine, Yost et al., 2019 report that the T cell clones that dominate the intra-tumoral T cell landscape after ICB are distinct from those prior to treatment, a phenomenon referred to by the authors as "clonal replacement."
Copyright © 2019 Elsevier Inc. All rights reserved.
Comment on
-
Clonal replacement of tumor-specific T cells following PD-1 blockade.Nat Med. 2019 Aug;25(8):1251-1259. doi: 10.1038/s41591-019-0522-3. Epub 2019 Jul 29. Nat Med. 2019. PMID: 31359002 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
